Spectrum of Severity of Multisystem Inflammatory Syndrome in Children: An EHR-based Cohort Study from the RECOVER program

Study Dates

2023

Last Modified

Tags




Publisher

PEDSnet

Abstract

Study to characterize the illness spectrum of MIS-C for improved recognition and management.

Funder(s)

This research was made possible through the generous support of the National Institutes of Health .

Provenance

Description

Multi-system inflammatory syndrome in children (MIS-C) is a severe post-acute sequela of SARS-CoV-2 infection in children, and there is a critical need to unfold its highly heterogeneous disease patterns. Our objective was to characterize the illness spectrum of MIS-C for improved recognition and management. We conducted a retrospective cohort study using data from March 1, 2020–September 30, 2022, in 8 pediatric medical centers from PEDSnet. We included 1139 children hospitalized with MIS-C and used their demographics, symptoms, conditions, laboratory values, and medications for analyses. We applied heterogeneity-adaptive latent class analyses and identified three latent classes. We further characterized the sociodemographic and clinical characteristics of the latent classes and evaluated their temporal patterns. Class 1 (47.9%) represented children with the most severe presentation, with more admission to the ICU, higher inflammatory markers, hypotension/shock/dehydration, cardiac involvement, acute kidney injury and respiratory involvement. Class 2 (23.3%) represented a moderate presentation, with 4–6 organ systems involved, and some overlapping features with acute COVID-19. Class 3 (28.8%) represented a mild presentation. Our results indicated that MIS-C has a spectrum of clinical severity ranging from mild to severe and the proportion of severe or critical MIS-C decreased over time.

Development Code

Vocabulary

Related Concept Set

Related Person

Related Data Quality Result

Related Person

Related Phenotype

Related Study

The Researching COVID to Enhance Recovery (RECOVER) Post-Acute Sequelae of SARS-CoV-2 (PASC) Electronic Health Record (EHR) Cohort Study
Children's Hospital of Philadelphia; Janssen (United States)
Study to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID.

Related Publications

Rao, S., Jing, N., Liu, X. et al. 2023. “Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program.” Scientific Reports. 13, 21005 (2023).
DOI:10.1038/s41598-023-47655-y

Creative Commons license

Except where otherwised noted, this item's license is described as a CC-BY 4.0 Attribution license.